Global Substance Abuse and Addiction Treatment Market - Industry Trends and Forecast to 2029

Market Analysis and Insights of Substance Abuse and Addiction Treatment Market

Data Bridge Market Research analyses that the substance abuse and addiction treatment will exhibit a CAGR of around 9.14% for the forecast period of 2022-2029. Growing demand for targeted mode of therapies, surge in the research and development activities for the development of novel drugs and therapies, surging prevalence of nicotine addiction and increased expenditure for the development of healthcare infrastructure are the major factors attributable to the growth of substance abuse and addiction treatment market.

From the name itself, it is clear that substance abuse and addiction treatment is a medical procedure that is used to help nicotine and similar substance addicted patients to get rid of them. Substance abuse refers to the use and addiction to psychoactive substances, including alcohol and illicit drugs.

Growing special designation from regulatory authorities is a major factor fostering the growth of the market. Rising expenditure on the development of healthcare infrastructure, growing development of targeted therapy drugs with low toxicity in combination with approved drugs, increase in the initiatives by the government to promote awareness in the backward areas, high rate of consumption of tobacco related products and upsurge in the strategic collaboration rate among the market players are other factors also fostering the growth of the market. Surging potential in emerging economies, effective treatment cost and easy availability of treatment options will create lucrative market growth opportunities.

However, dearth of skilled medical professionals and unfavourable reimbursement scenario in the developing and under developed economies will pose a major challenge to the market growth. Also, high costs associated with research and development proficiencies, poor treatment compliance in some countries, reluctance of individuals for accessing treatment and poor healthcare facilities in the underdeveloped economies will further derail the market growth rate.

This substance abuse and addiction treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on substance abuse and addiction treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Substance Abuse and Addiction Treatment Market Scope and Market Size

The substance abuse and addiction treatment market is segmented on the basis of types, treatment type, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• Based on types, the substance abuse and addiction treatment market is segmented into alcohol dependence, nicotine addiction, drug abuse.
• The treatment segment for substance abuse and addiction treatment market includes nicotine replacement therapy, psychotherapy, and alcohol addiction treatment.
• On the basis of route of administration, the substance abuse and addiction treatment market is segmented into oral and parenteral.
• Based on end-user, the substance abuse and addiction treatment market is segmented into hospitals, homecare, specialty clinics and others
• Substance abuse and addiction treatment market has also been segmented based on the distribution channel into hospital, pharmacy, online pharmacy, retail pharmacy and others.

Substance Abuse and Addiction Treatment Market Country Level Analysis

The substance abuse and addiction treatment market is segmented on the basis of types, treatment type, route of administration, end-users and distribution channel.

The countries covered in the substance abuse and addiction treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the substance abuse and addiction treatment market owing to the earliest adoption of innovative healthcare technologies, growing research and development, high prevalence rate, increasing adoption of novel dosage form and increase in health care awareness among people. Asia-Pacific is projected to undergo substantial gains during the forecast period and score the highest growth rate. This is because of the rising expenditure to develop healthcare infrastructure, high consumption rate of tobacco related products and increase in the research and development activities.

The country section of the substance abuse and addiction treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The substance abuse and addiction treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to substance abuse and addiction treatment market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the substance abuse and addiction treatment market in the growth period.

Competitive Landscape and Substance Abuse and Addiction Treatment Market Share Analysis

The substance abuse and addiction treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to substance abuse and addiction treatment market.

Some of the major players operating in the substance abuse and addiction treatment market are Hager Biosciences, LLC, ADDEX THERAPEUTICS, Omeros Corporation, Sosei Group Corporation, CV Sciences, Inc., Cerecor, Inc, Astraea Therapeutics LLC, Johnson & Johnson Services, Inc., GlaxoSmithKline plc, Pfizer Inc, Novartis AG, Sanofi, Dr. Reddy’s Laboratories Ltd, Teva Pharmaceutical Industries Ltd, Mylan N.V., Axsome Therapeutics, Inc, H. Lundbeck A/S, Zydus Cadila, Glenmark Pharmaceuticals Ltd., and F. Hoffman-La Roche Ltd., among others.

SKU-51818